 Platinum today | Boston Scientific Announces Canadian Approval and Launch of PROMUS Element ... Canada NewsWire (press release) NATICK, Mass., April 25, 2012 /CNW/ - Boston Scientific Corporation (NYSE: BSX) announces Health Canada approval and market launch of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System in Canada. Platinum coronary stent gets Canadian approval Boston Announces Canadian Approval, Launch Of PROMUS Element Plus Stent System |
